The global Glycobiology & Glycomics market size is predicted to grow from US$ 1224 million in 2025 to US$ 1479 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics is the systematic study of all glycan structures of a given cell type or organism and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, glyco-, and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).

Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.

Global Glycomics/Glycobiology key players include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, etc. Global top four manufacturers hold a share over 15%.

North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.

In terms of product, Instruments is the largest segment, with a share about 34%. And in terms of application, the largest application is Drug Discovery & Development, followed by Diagnostics, etc.

Infinity Market Research newest research report, the Glycobiology & Glycomics Industry Forecast looks at past sales and reviews total world Glycobiology & Glycomics sales in 2024, providing a comprehensive analysis by region and market sector of projected Glycobiology & Glycomics sales for 2025 through 2031. With Glycobiology & Glycomics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glycobiology & Glycomics industry.

This Insight Report provides a comprehensive analysis of the global Glycobiology & Glycomics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glycobiology & Glycomics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Glycobiology & Glycomics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glycobiology & Glycomics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glycobiology & Glycomics.

This report presents a comprehensive overview, market shares, and growth opportunities of Glycobiology & Glycomics market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Eagents
    Enzymes
    Kits
    Instruments

Segmentation by Application:

    Oncology
    Diagnostics
    Immunology
    Drug Discovery and Development
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Thermo Fisher Scientific
    Agilent Technologies
    New England Biolabs
    Waters Corp
    Bruker Corp
    Sigma-Aldrich Corp
    Takara Bio
    Prozyme
    Danaher Corp
    Shimadzu Corp

Key Questions Addressed in this Report

What is the 10-year outlook for the global Glycobiology & Glycomics market?
What factors are driving Glycobiology & Glycomics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glycobiology & Glycomics market opportunities vary by end market size?
How does Glycobiology & Glycomics break out by Type, by Application?